Q3 FY26 results: Rs.1 interim dividend, record date Feb 17 2026

Exceptional itemResults View source PDF Explain this filing

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.2%Reaction day

₹80.85

prior close

₹78.25

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-6.7% vs market

Pharmaceuticals peers, median of 159sector+0.0%-7.2% vs sector

On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 7.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-3.8

15m

-3.4

30m

-3.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.2-0.5-6.7+0.0-7.2

Next day

-7.8-1.0-6.8-0.2-7.6

-7.5-2.5-5.0-1.8-5.7

-7.7-3.2-4.5-2.3-5.4

-8.2-2.2-6.0-2.2-6.0

-8.7-1.9-6.8-1.8-6.9

-9.3-3.5-5.8-2.9-6.4

15d

-11.8-8.8-3.0-6.5-5.3

-11.6-9.3-2.3-6.6-5.0

+3.6-4.5+8.2-3.7+7.3

+34.4+5.4+29.0+2.9+31.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 revenue Rs. 580.39 Cr, up 10.9% YoY. 9M revenue Rs. 1,699.61 Cr, up 9.5%. 9M PAT Rs. 84.54 Cr vs Rs. 69.38 Cr. Q3 PAT flat at Rs. 20.58 Cr. Exceptional item of Rs. 11.21 Cr booked for Labour Codes impact. Pharmaceutical segment drove growth. Board declared Rs. 1 per share (50%) interim dividend. Record date Feb 17, 2026.

Likely market impact

Interim dividend signals healthy cash generation. Exceptional Labour Code charge weighed on Q3 PAT. Revenue growth strong in Pharma segment.